Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Faricimab showed efficacy in the treatment of naïve nAMD patients with an improvement of anatomical and functional parameters and a treatment interval after the loading phase equal or greater than 12 weeks in the majority of patients.
Authors
- Alberto Quarta (ORCID: https://orcid.org/0000-0002-0818-6124)
- Maria Ludovica Ruggeri (ORCID: https://orcid.org/0000-0002-5856-6686)
- Chiara De Nicola
- Marta Di Nicola (ORCID: https://orcid.org/0000-0003-1748-1931)
- Annamaria Porreca (ORCID: https://orcid.org/0000-0003-3278-1561)
- Lisa Toto (ORCID: https://orcid.org/0000-0001-5311-5184)
- Federico Formenti (ORCID: https://orcid.org/0000-0003-4289-0761)
- Rodolfo Mastropasqua (ORCID: https://orcid.org/0000-0003-1541-4735)
- Anna Maria Romano
- Luca Belloni Baroni
Institutions
- University of Chieti-Pescara (IT)
Publication Details
- Journal
- Ophthalmic Research
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1159/000540194
- Citations
- 4
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.15